Concepedia

Romy E. van Weelderen

RE

4

Publications

100

Citations

4

H-Index

2021

Active since

Affiliations

Vrije Universiteit Amsterdam(Current)

Emma Kinderziekenhuis

Princess Máxima Center

Amsterdam University Medical Centers

St. Jude Children's Research Hospital

Romy E. van Weelderen is an author at Vrije Universiteit Amsterdam specializing in molecular oncology, pathology, and cancer research.

ORCID

Top concepts

Publications per year

2021–2024

4

Publications

4

Measurable Residual Disease and Fusion Partner Independently Predict Survival and Relapse Risk in Childhood <i>KMT2A</i>-Rearranged Acute Myeloid Leukemia: A Study by the International Berlin-Frankfurt-Münster Study Group

Romy E. van Weelderen, Kim Klein, Christine J. Harrison et al. · Journal of Clinical Oncology · 2023 · 56 citations · Full text

Optimized cytogenetic risk-group stratification of <i>KMT2A</i>-rearranged pediatric acute myeloid leukemia

Romy E. van Weelderen, Christine J. Harrison, Kim Klein et al. · Blood Advances · 2024 · 21 citations · Full text

, , +15

Outcomes of pediatric acute myeloid leukemia treatment in Western Kenya

Romy E. van Weelderen, Festus Njuguna, Kim Klein et al. · Cancer Reports · 2021 · 13 citations · Full text

Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study

Kim Klein, H. Berna Beverloo, Martin Zimmermann et al. · Pediatric Blood & Cancer · 2021 · 10 citations

Rows per page

1–4 of 4